formoterol fumarate 0.005 MG/ACTUAT
- RxCUI
- 1246307
- RxNorm name
- formoterol fumarate 0.005 MG/ACTUAT
- Term type
- SCDC
- Status
- Active
- Updated
- 2026-10-20 20:47:52
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042012
- Active start
- 042012
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 5 MCG / 1 ACTUAT | formoterol |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| formoterol | 25255 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | formoterol fumarate 0.005 MG/ACTUAT | 1 | NAMES |
| RxNorm Name | formoterol fumarate 0.005 MG/ACTUAT | 1 | NAMES |
| TTY | SCDC | 1 | ATTRIBUTES |
| RxCUI | 1246307 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | R03AK | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics | ATC1-4 | formoterol / mometasone | |
| ATC | R03CC | Selective beta-2-adrenoreceptor agonists | ATC1-4 | formoterol | |
| ATC | R03AC | Selective beta-2-adrenoreceptor agonists | ATC1-4 | formoterol | |
| FDASPL | N0000175779 | beta2-Adrenergic Agonist | EPC | has_epc | formoterol |
| FDASPL | N0000009922 | Adrenergic beta2-Agonists | MOA | has_moa | formoterol |
| MEDRT | D000068759 | Formoterol Fumarate | CHEM | has_ingredient | formoterol fumarate |
| MEDRT | D000068759 | Formoterol Fumarate | CHEM | has_ingredient | formoterol |
| MEDRT | D000208 | Acute Disease | DISEASE | ci_with | formoterol fumarate |
| MEDRT | D000208 | Acute Disease | DISEASE | ci_with | formoterol |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | formoterol fumarate |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | formoterol fumarate |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | formoterol |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | formoterol |
| MEDRT | D001250 | Asthma, Exercise-Induced | DISEASE | may_prevent | formoterol fumarate |
| MEDRT | D001250 | Asthma, Exercise-Induced | DISEASE | may_prevent | formoterol |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_prevent | formoterol |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_treat | formoterol |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_treat | formoterol fumarate |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_prevent | formoterol fumarate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | formoterol |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | formoterol fumarate |
| MEDRT | N0000009922 | Adrenergic beta2-Agonists | MOA | has_moa | formoterol fumarate |
| MEDRT | N0000009922 | Adrenergic beta2-Agonists | MOA | has_moa | formoterol |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | formoterol |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | formoterol fumarate |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | formoterol |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | formoterol fumarate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | HYBRID |
| ATTRIBUTES | IN_EXPRESSED_FLAG | P |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | STRENGTH | 0.005 MG/ACTUAT |